|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 09007539.1 (espacenet) (Federated) (European Patent Register), 20030214 | Patent/reg. no. and date | DK/EP 2100615, 20160210 | Publication date | 20090916 | Priority no. and date | AU PS054702, 20020214 | EP pub. no. and date |
EP 2100615 20090916 | Effective date | | Applicant/owner | Biotempus Pty Ltd, Suite 01 Level 2 517 Flinders Lane
Melbourne VIC 3000, AU | Applicant ref. no. | | Inventor | Ashdown, Martin Leonard, 140 Keon Street Thornbury
Victoria 3071, AU | Representative | | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , G01N 33/574 (2006.01) , G01N 33/68 (2006.01) | Title | Cancer therapy | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |